Related Experiment Videos

Infection in vitro of the human pulmonary macrophage with Staphylococcus aureus (bacteriologic and ultrastructural

Morphologie Et Embryologie
|April 1, 1979
PubMed

Insights

Staphylococcus aureus multiplies within alveolar macrophages, suggesting a role in chronic lung infections. An antibiotic, pyopen, reduced bacterial numbers by inhibiting this intracellular growth.

Area of Science:

  • Pulmonary Medicine
  • Microbiology
  • Cell Biology

Background:

  • Alveolar macrophages are crucial for lung immunity.
  • Staphylococcus aureus is a common cause of bacterial pneumonia.
  • Intracellular bacterial growth can complicate treatment.

Purpose of the Study:

  • To investigate Staphylococcus aureus intracellular multiplication within human alveolar macrophages.
  • To assess the effect of the antibiotic pyopen on intracellular bacterial growth.
  • To explore the mechanisms of bacterial survival and host cell interaction.

Main Methods:

  • In vitro infection of human alveolar macrophages with Staphylococcus aureus.
  • Bacteriologic seeding of extracellular and intracellular bacteria.
  • Treatment with the antibiotic pyopen.
  • Electron microscopy for ultrastructural analysis.

Main Results:

  • Staphylococcus aureus exhibited significant intracellular multiplication within alveolar macrophages.
  • Pyopen treatment decreased bacterial load by inhibiting intracellular multiplication.
  • Electron microscopy showed reduced phagolysosomal fusion and bacterial structural alterations.

Conclusions:

  • Alveolar macrophages support Staphylococcus aureus intracellular proliferation.
  • Antibiotic inhibition of intracellular growth is a key factor in controlling infection.
  • Cellular parasitism by S. aureus is important in chronic bronchopulmonary infections.

Related Concept Videos